SCHEMBL3374752

SCHEMBL3374752

CC(C)c1cccc(CN2CCC(F)CC2)c1-c1cccs1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.38
DRD4 P21917 2/20 0.38
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ACHE P22303 2/20 0.35
CHRM4 P08173 3/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 3/20 0.35
DRD3 P35462 1/20 0.35
LMNA P02545 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
HTR7 P34969 3/20 0.34
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374256 0.68 CXCR3 (0.42) DRD2DRD4MEN1KMT2APOLB
SCHEMBL23939174 0.65 CYP2A13 (0.58) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL3372885 0.63 KDM4E (0.37) DRD2DRD4MEN1KMT2APOLB
SCHEMBL15614461 0.63 MC4R (0.53) DRD4KMT2APOLBKDM4EALDH1A1
SCHEMBL14380993 0.62 ALDH1A1 (0.53) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL31448683 0.62 CYP2A13 (0.69) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL4111089 0.62 CYP2A13 (0.63) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL13594974 0.61 ALDH1A1 (0.56) MEN1KMT2APOLBKDM4ENPSR1
SCHEMBL4711132 0.60 KMT2A (0.62) MEN1KMT2AKDM4ENPSR1MAPT
SCHEMBL31653411 0.59 HTT (0.56) DRD2DRD4POLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010045006-A1 METHYLENE AMINES OF THIENO [2,3-D] PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2010-04-22 WO disclosed